IL6 and inflammatory bowel disease: IL-6, which links inflammatory bowel disease (IBD), AGE-RAGE, JAK/STAT, PI3K/Akt, cytokine–cytokine receptor interaction, and EGFR-TKI-resistance signaling pathways, was upregulated by the SYN treatment versus the PL treatment.